Kathmandu
Cancer Center
Kathmandu
Cancer Center
Breast check, mammography, breast lump evaluation and breast cancer care at KCC.
Whether you need a routine breast check, have found a breast lump, or have an abnormal mammogram, our team can guide you through assessment, diagnosis and treatment in one cancer center.
KCC Main Center, Tathali, Bhaktapur · City Clinic, New Baneshwor, Kathmandu
Three common reasons people come to KCC — each with its own clear next step.
Clinical breast examination and, from age 40, a screening mammogram every 1–2 years. No referral needed.
Same-week specialist assessment with ultrasound and/or mammogram, and biopsy if indicated. Results in 3–5 days.
Complete treatment under one roof — surgery, chemo, targeted therapy, immunotherapy and radiotherapy — decided by KCC's tumour board.
Most breast clinics stop at consultation. KCC is a full cancer centre — so if anything is found, treatment starts here, not somewhere else.
Clinical breast examination · Digital mammogram · Breast ultrasound when indicated
Breast specialist consultation · Additional imaging (MRI when indicated)
Image-guided core needle biopsy · Pathology · ER/PR/HER2/Ki-67
Surgery · Chemotherapy · Targeted therapy · Immunotherapy · Radiotherapy
Surveillance · Rehabilitation · Long-term follow-up
During Pink October, Kathmandu Cancer Center is offering routine mammogram screening for Rs. 1,250 instead of Rs. 2,500.
The offer is available during October–November 2026. Conditions apply. Diagnostic mammograms and ultrasound, when clinically required, may be charged separately.
View mammogram details and book your screening or call 01-5091629 / 9818-226237.
She noticed it while getting dressed : a small lump, maybe the size of a marble. She pressed it once, told herself it was probably nothing, and got on with her day. Six months later she was sitting across from a surgeon, being told that was cancer.
We hear this story often — not because Nepali women are careless, but because breast cancer in its early stages usually causes no pain. A lump that doesn't hurt is still a lump that needs to be checked.
None of these signs confirm cancer on their own — but all of them deserve a doctor's check-up, not just waiting.
Arrange a clinic visit if you notice a new breast or underarm lump, a persistent change in breast shape or size, nipple inversion, unusual discharge, skin dimpling, redness, or thickening that does not settle within one to two weeks. Rapid-onset breast redness and swelling — even without a distinct lump - needs prompt same-week assessment. Many breast changes turn out not to be cancer, but a change is not something to self-diagnose from this page or internet.
Most lumps in women under 40 are non-cancerous, but feel alone cannot tell it is cancer or not . KCC uses three steps together: a clinical checkup-exam, imaging (ultrasound and/or mammogram), and a core needle biopsy with results in three to five days. Used together, these three steps give a very reliable diagnosis — far more reliable than any one step alone — and every confirmed case is reviewed at KCC's team of experts before treatment begins.
A mammogram can find cancer years before it's large enough to feel. Most cancers found through screening are at an early, simpler-to-treat stage. KCC offers digital mammography in Bhaktapur hospital.
A properly performed core needle biopsy does not cause cancer to spread - this is one of the most persistent fears we hear, and it is not supported by evidence. Delaying a biopsy because of this fear only delays diagnosis and treatment.
Breast cancer is not the same in every person. After a biopsy, the cancer cells are tested to understand what type of breast cancer it is and which treatments are most likely to help.
A breast biopsy tells us whether a lump is cancer and gives important information about the cancer cells. Doctors may then test the tumour for markers such as ER, PR and HER2. These tests help determine how the cancer behaves and which medicines may be useful.
Some breast cancers are sensitive to hormones and can be treated with hormone-blocking medicines. Some have high levels of HER2 and may benefit from HER2-targeted treatment. Others do not have these markers and may need a different combination of treatments.
Your treatment is therefore based on more than the size of the tumour. The biopsy, biomarker tests, stage, lymph nodes and your overall situation are considered together.
Every new breast cancer diagnosis at KCC is tested for at least these four markers before treatment starts — together they decide the entire plan, more than the tumour's size alone.
Treatment is chosen based on the cancer's stage, subtype, and your individual factors — not a fixed formula. It may include one or a combination of the following, decided at KCC's multidisciplinary tumour board.
One of the first questions after a diagnosis is whether the breast can be saved. For most women with early-stage cancer, the answer is yes — and the choice is always yours after an honest explanation of both options.
Removes the tumour with a clear margin, preserving the breast. Always followed by radiotherapy.
Removes the entire breast, chest wall muscles preserved. Reconstruction is discussed beforehand.
Accurate nodal staging shapes the rest of the treatment plan.
Immediate or delayed, planned pre-operatively and timed around any radiotherapy.
For large HER2+ or triple-negative tumours, chemotherapy before surgery can make breast-conserving surgery possible.
Every surgery is reviewed by a multidisciplinary board first — a consensus plan, not one doctor's opinion.
Used before surgery to shrink a tumour, after surgery to lower recurrence risk, or for cancer that has spread. Most chemotherapy at KCC is a same-day infusion — you come in, are treated over a few hours, and go home the same day.
Radiation after surgery cuts the risk of local recurrence by roughly half. KCC uses advanced and safe RT technique like IMRT and VMAT, which shapes the beam precisely around breast tissue, reducing dose to the heart and lungs.
Given over three to five weeks, with a boost dose for selected patients.
Recommended for four or more positive nodes, larger tumours, or positive margins.
The heart sits close to the treatment area on the left side. DIBH moves it out of the way during each beam.
Short courses to control bone pain or other symptoms from spread.
Heart sits close to the chest wall, near the treatment field.
Lungs expand, chest moves forward, heart drops away from the field.
About 70% of breast cancers are fuelled by estrogen and progesterone — HR-positive breast cancer. Treatment blocks these hormones so the cancer cannot grow, usually as a daily tablet at home.
Daily tablet, typically taken for 5 to 10 years.
Preferred first-line hormone therapy after menopause.
Added to hormone therapy; has significantly improved outcomes in recent years.
About 1 in 5 breast cancers has extra HER2 protein on the cell surface. HER2-positive cancer tends to grow faster — but responds remarkably well to targeted therapy designed specifically to block that protein.
Both trastuzumab and pertuzumab are available at KCC's Day Ward.
For eligible triple-negative patients, immunotherapy (pembrolizumab) combined with chemotherapy is available. For BRCA1/2-mutated cancers, PARP inhibitors such as olaparib may be considered — genetic testing can be arranged at KCC.
Your specific path is decided at KCC's tumour board — surgeon, medical oncologist, radiation oncologist and pathologist together.
Core biopsy · ER/PR/HER2/Ki-67 · Staging · BRCA for selected cases
Chemo ± targeted therapy before surgery — shrinks the tumour, tests response
Lumpectomy or mastectomy + node dissection · Reconstruction discussed
Whole-breast or post-mastectomy IMRT · Heart-sparing DIBH for left-sided cancer
Hormone therapy 5–10 yrs (HR+) · Targeted therapy to 12 months (HER2+)
After treatment ends, most women return to work and normal routines within weeks to months. KCC schedules regular follow-up to catch any recurrence early. If you may want children after treatment, raise this at your very first consultation — before chemotherapy begins, since fertility preservation has a narrow window.
Cost varies with the stage of cancer and the combination of surgery, chemotherapy, radiotherapy, hormone therapy and targeted therapy required — there is no single fixed price for "breast cancer treatment." After your first consultation and biomarker results, KCC provides a written estimate covering each stage of treatment, so there are no surprises later. Ask for this estimate at your first visit, and compare it openly against quotes from any other hospital, in Nepal or abroad.
Coming from Pokhara, Dharan, Butwal, Nepalgunj, or anywhere else in Nepal? Send your existing reports over WhatsApp before you travel — KCC's team can review them and give preliminary guidance, so your first visit is more useful and your trip is planned around real next steps. Free pickup within the Ring Road is available for outstation patients.
Already have reports from an Indian hospital? KCC follows the same international guidelines (NCCN) used across major Indian cancer centres. Bring your existing records — surgical pathology, ER/PR/HER2/Ki-67 results, imaging, and chemotherapy details — and treatment can continue from where it was left off, without starting over.
Initial breast consultation with a specialist, including access to Nepal's first female breast oncosurgeon. Most convenient for patients in central Kathmandu.
Consultation · Clinical breast exam · Referral for imaging
Digital mammography, breast ultrasound, biopsy, pathology, surgery, chemotherapy, radiotherapy and complete cancer treatment — all in one campus.
Mammogram · Ultrasound · Biopsy · Surgery · Chemo · Radiotherapy
Breast cancer treatment at KCC is performed by more than one specialistby surgeons , alongside coordinated oncology, radiology and pathology support.
You do not need to decide which specialist to see before contacting KCC — message your symptoms or reports on WhatsApp and the team will offer you the soonest available breast surgery consultation.
View All KCC Specialists →Treatment information on this page follows guidelines from the National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the St Gallen International Breast Cancer Conference consensus. It is reviewed periodically by KCC's breast oncology team and is provided as general information only — it does not replace individual clinical assessment.
लक्षण, उपचार, खर्च, र भारत नजानी नेपालमै उपचार गर्नेबारे पूरा जानकारी नेपालीमा पढ्नुहोस्।
City Clinic — New Baneshwor, Kathmandu · Main Campus — Tathali, Bhaktapur
Book Appointment
